Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience-Reference-Cited by-同舟云学术

Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience

Published:2021-04 Issue: Volume:220 Page:153410
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Rizzo Alessandro,Mollica Veronica,Giunchi Francesca,Dall’Olio Filippo Gustavo^ORCID,Rosellini Matteo^ORCID,Marchetti Andrea^ORCID,Franceschini Tania,Schiavina Riccardo,Brunocilla Eugenio,Fiorentino Michelangelo,Ardizzoni Andrea,Massari Francesco^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference26 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

2. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base;Smith;BJU Int.,2014

3. Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis;Rizzo;Eur. Urol. Focus,2021

4. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma;Galsky;Ann. Oncol.,2012

5. Current status and future direction of immunotherapy in urothelial carcinoma;Lattanzi;Curr. Oncol. Rep.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A ratiometric electrochemical biosensor based on ARGET ATRP for detection of HER2 gene;Talanta;2024-08

2. Expression of HER2 in urothelial carcinoma and its significance;Current Urology;2024-05-27

3. Genomics and Immunomics in the Treatment of Urothelial Carcinoma;Current Oncology;2022-05-12